abrdn Life Sciences Investors Shares of Beneficial Interestabrdn Life Sciences Investors Shares of Beneficial Interestabrdn Life Sciences Investors Shares of Beneficial Interest

abrdn Life Sciences Investors Shares of Beneficial Interest

No trades
See on Supercharts

HQL fundamentals

abrdn Life Sciences Investors Shares of Beneficial Interest financial statements, including revenue, expenses, and profit

The total revenue of HQL for the last semiannual is 36.16 M USD, and it's 16158.45% higher compared to the previous semiannual. The net income of H2 24 is 35.04 M USD.

Total revenue
Operating income
Pretax income
Net income
Currency: USD
TTM
Total revenueYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth